MRL Ventures Fund
Investor profile
Venture capital
Deals
4
distinct rounds
Companies
3
backed
Active span
2022–2023
2 yrs
Total round €
€201M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| EyeBiotech | UK | 2 | €117M |
| Ambagon Therapeutics | Netherlands | 1 | €75M |
| Anavo Therapeutics | Netherlands | 1 | €8.5M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Ambagon Therapeutics | Series A | €75M | 2022-01 |
| EyeBiotech | Series A | €60M | 2023-11 |
| EyeBiotech | Series A | €57M | 2022-02 |
| Anavo Therapeutics | Seed | €8.5M | 2023-05 |